| ATM deficiency sensitizes mantle cell lymphoma cells to poly (ADP-ribose) polymerase-1 inhibitors CT Williamson, H Muzik, AG Turhan, A Zamò, MJ O'Connor, DG Bebb, ... Molecular cancer therapeutics 9 (2), 347-357, 2010 | 207 | 2010 |
| Evaluation of immunohistochemical markers in non‐small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers NHC Au, M Cheang, DG Huntsman, E Yorida, A Coldman, WM Elliott, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004 | 173 | 2004 |
| Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes RJ de Leeuw, JJ Davies, A Rosenwald, G Bebb, RD Gascoyne, MJS Dyer, ... Human molecular genetics 13 (17), 1827-1837, 2004 | 149 | 2004 |
| Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53 CT Williamson, E Kubota, JD Hamill, A Klimowicz, R Ye, H Muzik, M Dean, ... EMBO molecular medicine 4 (6), 515-527, 2012 | 145 | 2012 |
| Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines E Kubota, CT Williamson, R Ye, A Elegbede, L Peterson, SP Lees-Miller, ... Cell cycle 13 (13), 2129-2137, 2014 | 143 | 2014 |
| Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challenges NA Nixon, N Blais, S Ernst, C Kollmannsberger, G Bebb, M Butler, ... Current oncology 25 (5), 373-384, 2018 | 136 | 2018 |
| Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity WK Boland, G Bebb Expert opinion on biological therapy 9 (9), 1199-1206, 2009 | 130 | 2009 |
| ATM-deficient colorectal cancer cells are sensitive to the PARP inhibitor olaparib C Wang, N Jette, D Moussienko, DG Bebb, SP Lees-Miller Translational oncology 10 (2), 190-196, 2017 | 109 | 2017 |
| The CXCR4/SDF-1 chemokine receptor axis: a new target therapeutic for non-small cell lung cancer S Otsuka, G Bebb Journal of Thoracic Oncology 3 (12), 1379-1383, 2008 | 93 | 2008 |
| Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV … G Bebb, C Smith, S Rorke, W Boland, L Nicacio, R Sukhoo, A Brade Cancer chemotherapy and pharmacology 67, 837-845, 2011 | 90 | 2011 |
| CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer S Otsuka, AC Klimowicz, K Kopciuk, SK Petrillo, M Konno, D Hao, H Muzik, ... Journal of Thoracic Oncology 6 (7), 1169-1178, 2011 | 77 | 2011 |
| The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status M Kim, CT Williamson, J Prudhomme, DG Bebb, K Riabowol, PWK Lee, ... Oncogene 29 (27), 3990-3996, 2010 | 75 | 2010 |
| Physical activity and diet behaviour in colorectal cancer patients receiving chemotherapy: associations with quality of life LE Stephenson, DG Bebb, RA Reimer, SN Culos-Reed BMC gastroenterology 9, 1-9, 2009 | 74 | 2009 |
| Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment D Hao, MO Sarfaraz, F Farshidfar, DG Bebb, CY Lee, CM Card, M David, ... Metabolomics 12, 1-9, 2016 | 73 | 2016 |
| Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients TJ Pugh, G Bebb, L Barclay, M Sutcliffe, J Fee, C Salski, R O'Connor, ... BMC cancer 7, 1-12, 2007 | 57 | 2007 |
| Bias and variability in blood pressure measurement with ambulatory recorders. G Pannarale, G Bebb, S Clark, A Sullivan, C Foster, AJ Coats Hypertension 22 (4), 591-598, 1993 | 57 | 1993 |
| The lung immune prognostic index discriminates survival outcomes in patients with solid tumors treated with immune checkpoint inhibitors DE Meyers, I Stukalin, IA Vallerand, RT Lewinson, A Suo, M Dean, ... Cancers 11 (11), 1713, 2019 | 56 | 2019 |
| Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North America C Ho, N Murray, J Laskin, B Melosky, H Anderson, G Bebb Lung Cancer 49 (2), 225-231, 2005 | 55 | 2005 |
| Shame, guilt, and communication in lung cancer patients and their partners D Dirkse, L Lamont, Y Li, A Simonič, G Bebb, J Giese–Davis Current Oncology 21 (5), 718-722, 2014 | 53 | 2014 |
| Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer DG Bebb, Z Yu, J Chen, M Telatar, K Gelmon, N Phillips, RA Gatti, ... British journal of cancer 80 (12), 1979-1981, 1999 | 52 | 1999 |
